focus -WSS

focus

author：Wikipedia 2025-09-07 17:26:59 - browse：197

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Readout LOUD Podcast: Legal insider trading, booming biotech stocks

WSS

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

In search for therapies for solid tumors, companies turn to claudin

Grad students accuse University of California of wage theft

Transgender sports debate: Physicians say bans are health issue

The struggle to figure out which patients 'deserve' Wegovy

White House Covid adviser calls on docs to combat misinformation

leisure time

focus

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Covid isolation guidance eased by the CDC

Hollywood unions extend contract negotiations for actors

Congress gives doctors Medicare pay bump

How to save PrEP access — and even expand it

FDA does about

What does generative AI mean for health care? We asked experts

David Liu startup to focus on CRISPR delivery

BioMarin wins approval for gene therapy to treat hemophilia A

Why getting cancer drugs just got harder for rural patients

entertainment

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Grad students accuse University of California of wage theft

Free Covid tests will again be offered to all U.S. households

Why getting cancer drugs just got harder for rural patients

Senate bill would ban some hospital facility fees

Clinical trials giant ICON acquires HumanFirst

focus

explore

Wikipedia

hotspot